Catalepsy - Physiopathology
Research News and Information

Monday, November 23, 2009

[Effect of sulpiride on immobility reflex and pinch-induced catalepsy in CBA/Lac male mice with various social status]

29 Jun 2009 This study was aimed to determine the effect of D2/D3 receptor antagonist sulpiride on the expression of immobility reflex ("pinch-test") and pinch-induced catalepsy ("bar-test") of CBA/Lac male mice depending on their social status ("aggressors" ... Read more...

Narcolepsy--master of disguise: evidence-based recommendations for management.

29 Apr 2009 Narcolepsy is a neurological disorder affecting the regulation of sleep and wakefulness. It is characterized by excessive daytime sleepiness, cataplexy, and other rapid eye movement (REM) sleep-associated manifestations (eg, hypnagogic ... Read more...

[Effects of chronic fluoxetine treatment on catalepsy and immune response in mice genetically predisposed to freezing reaction: the role of 5-HT1A and 5-HT2A receptors and tph2 and SERT genes]

27 Feb 2009 ASC/Icg (Antidepressant Sensitive Catalepsy) mouse strain selected for high predisposition to pinch-induced catalepsy is characterized by depressive-like behavior and impaired immune response. Chronic treatment with SSRI fluoxetine attenuated ... Read more...

Latest indexed articles for 'Catalepsy - Physiopathology'

These are the very latest articles for this heading:

• [Effect of sulpiride on immobility reflex and pinch-induced catalepsy in CBA/Lac male mice with various social status] 29 Jun 2009
• Narcolepsy--master of disguise: evidence-based recommendations for management. 29 Apr 2009
• [Effects of chronic fluoxetine treatment on catalepsy and immune response in mice genetically predisposed to freezing reaction: the role of 5-HT1A and 5-HT2A receptors and tph2 and SERT genes] 27 Feb 2009
• In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration. 30 Jan 2009
• Cortical effects of subthalamic stimulation correlate with behavioral recovery from dopamine antagonist induced akinesia. 9 Sep 2008
• [The investigation of cataleptic muscle tonus changes in rats after audiogenic seizures] 30 Aug 2008
• The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates. Jul 2008
• [Chronic effect of thyroxine on behavior and brain serotonin receptors in mice with the sharp difference in predisposition to catalepsy] 29 Jun 2008
• Extracellular signal-regulated kinases (ERK) and protein kinase C (PKC) activities are involved in the modulation of Nur77 and Nor-1 expression by dopaminergic drugs. May 2008
• Increased left prefrontal activation during staring/mutism episodes in a patient with resistant catatonic schizophrenia: a near infrared spectroscopy study. 28 Feb 2008
• Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism. 10 Oct 2007
• Alteration of behavior in mice by muscimol is associated with regional electroencephalogram synchronization. 11 Jun 2007
• Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice. 20 May 2007
• Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia. 7 Dec 2006
• Identification of a new functional target of haloperidol metabolite: implications for a receptor-independent role of 3-(4-fluorobenzoyl) propionic acid. 29 Sep 2006
• EFNS guidelines on management of narcolepsy. 29 Sep 2006
• Histamine H3 receptor agonist- and antagonist-evoked vacuous chewing movements in 6-OHDA-lesioned rats occurs in an absence of change in microdialysate dopamine levels. 14 Sep 2006
• Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice. 4 Sep 2006
• In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles. 30 Aug 2006
• [Objective EEG correlates of deprivation in hypnosis-modulated catalepsy] 30 Dec 2005

See a longer list of these articles.

Technical information about 'Catalepsy'

Definition: A condition characterized by inactivity, decreased responsiveness to stimuli, and a tendency to maintain an immobile posture. The limbs tend to remain in whatever position they are placed (waxy flexibility). Catalepsy may be associated with PSYCHOTIC DISORDERS (e.g., SCHIZOPHRENIA, CATATONIC), nervous system drug toxicity, and other conditions.

Descriptor UI: D002375

Alternative terms: Catalepsy; Catalepsies; Anochlesia; Anochlesias; Cerea Flexibilitas; Flexibilitas, Cerea; Flexibility, Waxy; Flexibilities, Waxy; Waxy Flexibilities; Waxy Flexibility;

Related Mesh Headings: Cataplexy; Catatonia; Freezing Reaction, Cataleptic;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C10.597.350.200; C23.888.592.350.200;

Technical Notes: do not confuse with CATAPLEXY